Dr. Wafaa El-Sadr named Dr. Mathilde Krim-amfAR Chair of Global Health

November 17, 2015

November 17, 2015 -- The Trustees of Columbia University have approved a new endowed professorship in global health at the Mailman School of Public Health. The inaugural recipient is Dr. Wafaa El-Sadr, professor of Epidemiology and director of ICAP and an internationally recognized leader in prevention and care of people with HIV/AIDS globally. Through the generosity of the Hess Foundation at the bequest of Norma Hess, and of amfAR The Foundation for AIDS Research, Dr. El-Sadr will be the Dr. Mathilde Krim-amfAR Chair of Global Health.

This professorship honors Dr. El-Sadr as a global health pioneer. As the director of ICAP, established in 2003 to conduct transformative care delivery and prevention, as well as research to improve the lives of people around the world, Dr. El-Sadr, has led the historic scale-up of access to treatment in some of the countries most severely affected by HIV. Today one of every five people being treated for HIV--2.2 million people in more than 20 countries in sub-Saharan Africa and Asia--does so with ICAP support. Together with colleagues in New York and around the world, Dr. El-Sadr has in a visionary and effective way, enhanced laboratory, technical and clinical infrastructure in partnership with leaders in-country, and developed education and mentorship for those providing care and extending prevention. In 2008, Dr. El-Sadr was named a John D. and Catherine T. MacArthur Foundation Fellow, also known as the Genius Award, for her creativity, originality, and potential to make important contributions for the future.

Beyond leading in implementation and scale-up of HIV/AIDS programs, Dr. El-Sadr has championed the importance of knowledge-generation, furthering ICAP's vibrant research agenda. These contributions have advanced knowledge in HIV prevention and treatment, management of HIV, tuberculosis and other conditions, and prevention of mother-to-child HIV transmission. In the last year, ICAP embarked on the Population-based HIV Impact Assessment project, a major endeavor to assess the status of the HIV epidemic in several sub-Saharan African countries with support from the U.S. Centers for Disease Control and Prevention.

As a highly regarded educator, Dr. El-Sadr is also University Professor and professor of Medicine at Columbia University Medical Center, and works with Master's and doctoral students from all over the Mailman School pursuing careers in global health and infectious disease. She also leads the Global Health Initiative, working to foster interdisciplinary collaborations on key global health issues across our school. She maintains a practice at Harlem Hospital where she has provided care to patients with HIV for several decades.

"Dr. El-Sadr has brought global distinction to the Mailman School and Columbia University, warm collegiality to researchers and public health leaders all over the world, and humanity and empathy to those living with HIV and AIDS," said Linda P. Fried, MD, MPH, dean of the Mailman School and DeLamar Professor of Public Health Practice. "It is particularly appropriate that this professorship is named for Dr. Mathilde Krim, a legend in the HIV response."

"It has been a privilege to have worked with so many remarkable people over the past decades," said Dr. El-Sadr. "They have been the true inspiration behind all of my work."

As a co-founder of the AIDS Medical Foundation in 1983, Dr. Krim was at the forefront of philanthropic and scientific responses to AIDS long before the world fully understood its catastrophic global reach. Two years later, AMF joined forces with Elizabeth Taylor's California-based National AIDS Research Foundation to form the American Foundation for AIDS Research--amfAR. As Board Chair for two decades, Dr. Krim presided over a research portfolio that contributed to the development of new classes of antiretroviral drugs, modeled the first successful community-based clinical trials network, and founded a collaborative research and education network focused on Asia's growing HIV epidemic. She was also a driving force behind the development and passage of legislation that remains the backbone of the federal response to AIDS. Dr. El-Sadr herself served as a member of amfAR's Board for several years and was honored by amfAR for her groundbreaking research on women and HIV/AIDS on World AIDS Day 2004. An insightful scientist, Dr. Krim served as a member of the Mailman School's Board of Overseers and partnered with many members of our faculty to raise understanding about the importance of fighting stigma and ignorance with the same urgency scientists used to combat the virus.

The Hess Foundation has given significant funding to Columbia University, and in particular, to our School. They have supported, among other things, Hess Commons, and the Leon Hess Professorship in Environmental Health Sciences, held by the department chair. Leon and Norma Hess were close friends of Joseph and Phyllis Mailman. Betsy Williams, their granddaughter and a graduate of the school, has served on the Mailman School Board of Overseers since 2007. Ms. Williams's leadership and support made this gift possible and she herself works closely with many Mailman School faculty and students.
-end-
About Columbia University's Mailman School of Public Health

Founded in 1922, Columbia University's Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 450 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,300 graduate students from more than 40 nations pursuing a variety of master's and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including ICAP (formerly the International Center for AIDS Care and Treatment Programs) and the Center for Infection and Immunity. For more information, please visit http://www.mailman.columbia.edu

Columbia University's Mailman School of Public Health

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.